Simplify Logo

Full-Time

Director – National Accounts

Posted on 5/15/2024

Axsome Therapeutics Inc

Axsome Therapeutics Inc

501-1,000 employees

Develops therapies for central nervous system conditions

Hardware
Biotechnology

Senior

New York, NY, USA

Category
Healthcare Administration & Support
Physicians & Surgeons
Medical, Clinical & Veterinary
Required Skills
Communications
Marketing
Requirements
  • Bachelor’s Degree in business, marketing, economics, or health sciences
  • Minimum 5-10 years of successful National Account Management experience
  • Experience gaining formulary access for a launch product at multiple national and regional payer accounts and PBMs
  • Previous experience at a pre-commercial biopharmaceutical company
  • Negotiation experience, preferably in competitive primary care therapeutic areas
  • Analytical mindset and history of leveraging HEOR data
  • Problem-solving mindset with a demonstrated 'lean-forward' approach
  • Strong understanding of the payer landscape and how payer decision making impacts providers and patients
  • Excellent oral, written, and presentation skills
  • Previous product launch experience, preferably in the CNS space
  • Familiarity with current legal and regulatory landscape pertinent to the industry
Responsibilities
  • Ensure disciplined and effective communication with key payer stakeholders and decision makers
  • Execute the payer engagement strategy to obtain appropriate access/formulary position among target accounts
  • Profile key payer accounts to assess formulary review process and coverage policies
  • Identify and address potential barriers to access proactively
  • Develop strategies to ensure optimal coverage for the company's portfolio of products
  • Lead initiatives to capitalize on formulary wins and address access challenges
  • Ensure compliance with corporate policies and U.S. healthcare laws and regulations
Axsome Therapeutics Inc

Axsome Therapeutics Inc

View

With a dedicated focus on developing therapies for central nervous system conditions—such as depression, Alzheimer’s disease agitation, and fibromyalgia—this company stands out by addressing critical unmet medical needs with promising products like AXS-05 and AXS-07. The firm fosters a culture deeply committed to innovation and the development of therapies with novel mechanisms of action, showcasing strong potential in the medical field and enhancing patient care in areas with limited treatment options.

Company Stage

IPO

Total Funding

$430.7M

Headquarters

New York City, New York

Founded

2012

Growth & Insights
Headcount

6 month growth

110%

1 year growth

110%

2 year growth

110%
INACTIVE